 |
Previous Article | Next Article 
The Journal of Neuroscience, August 15, 2001, 21(16):5944-5951
Neuronal CaV1.3 1 L-Type Channels
Activate at Relatively Hyperpolarized Membrane Potentials and Are
Incompletely Inhibited by Dihydropyridines
Weifeng
Xu and
Diane
Lipscombe
Department of Neuroscience, Brown University, Providence, Rhode
Island 02912
 |
ABSTRACT |
L-type calcium channels regulate a diverse array of cellular
functions within excitable cells. Of the four molecularly defined subclasses of L-type Ca channels, two are expressed ubiquitously in the
mammalian nervous system (CaV1.2 1 and
CaV1.3 1). Despite diversity at the
molecular level, neuronal L-type channels are generally assumed to be
functionally and pharmacologically similar, i.e., high-voltage
activated and highly sensitive to dihydropyridines. We now show that
CaV1.3 1 L-type channels activate at membrane potentials ~25 mV more hyperpolarized, compared with
CaV1.2 1. This unusually negative activation
threshold for CaV1.3 1 channels is
independent of the specific auxiliary subunits coexpressed, of
alternative splicing in domains I-II, IVS3-IVS4, and the C terminus,
and of the expression system. The use of high concentrations of
extracellular divalent cations has possibly obscured the unique voltage-dependent properties of CaV1.3 1 in
certain previous studies. We also demonstrate that
CaV1.3 1 channels are pharmacologically distinct from CaV1.2 1. The IC50
for nimodipine block of CaV1.3 1 L-type
calcium channel currents is 2.7 ± 0.3 µM, a value
20-fold higher than the concentration required to block
CaV1.2 1. The relatively low sensitivity of
the CaV1.3 1 subunit to inhibition by
dihydropyridine is unaffected by alternative splicing in the IVS3-IVS4
linker. Our results suggest that functional and pharmacological criteria used commonly to distinguish among different Ca currents greatly underestimate the biological importance of L-type channels in
cells expressing Cav1.3 1.
Key words:
CaV1.3 1; L-type; voltage-gated
calcium channel; dihydropyridine; low threshold; R-type; clone; Xenopus oocytes; HEK 293
 |
INTRODUCTION |
L-type calcium channels couple
excitation to contraction in muscle, to gene expression in neurons, to
hormone secretion in endocrine cells, and to transmitter release in
hair cells (Beam et al., 1989 ; Ashcroft et al., 1994 ; Fuchs, 1996 ;
Finkbeiner and Greenberg, 1998 ). Four genes encode L-type
CaV1 1 subunits in mammals (Ertel et al., 2000 ).
CaV1.2 1
( 1C) and
CaV1.3 1
( 1D) are the two most widely expressed L-type
channel subunits, and together they are thought to underlie L-type
currents in neurons (Hell et al., 1993 ). Despite reports of functional
diversity among L-type currents in select cells, notably endocrine
cells, hippocampal neurons, and hair cells (Smith et al., 1993 ; Avery
and Johnston, 1996 ; Kavalali and Plummer, 1996 ; Platzer et al., 2000 ),
L-type channels are often assumed to be high voltage-activated and
dihydropyridine-sensitive (Ertel et al., 2000 ). These defining criteria
are used to establish the involvement of L-type channel in Ca signaling
in a variety of cell types, including neurons. Functional studies of
recombinant CaV1.2 1
subunits have confirmed that they form prototypic, high voltage-activated, long-lasting, dihydropyridine-sensitive L-type currents (Mori et al., 1993 ). However, comparable studies of
CaV1.3 1 are limited
(Williams et al., 1992 ; Ihara et al., 1995 ; Bell et al., 2001 ). We
report that CaV1.2 1 and
CaV1.3 1 L-type channels are significantly different both at the functional and pharmacological level, contrary to current classification schemes (Ertel et al., 2000 ).
Our results suggest that functional and pharmacological criteria
currently used to establish the relative contributions of different Ca
channels to various signaling pathways will greatly underestimate the
biological importance of L channels in cells that express
CaV1.3 1. Their unique
voltage dependence of activation also implies that
CaV1.3 1 L-type Ca
channels mediate cellular processes that depend on calcium influx at
relatively hyperpolarized membrane potentials (Liljelund et al.,
2000 ).
 |
MATERIALS AND METHODS |
Cloning. Full-length
CaV1.3 1 cDNAs were
constructed from overlapping rat superior cervical ganglia library- and
RT-PCR-derived cDNAs. Library screening and RT-PCR methods have been
described previously (Lin et al., 1997 ). The Expand High Fidelity PCR
system (Roche Molecular Biochemicals, Indianapolis, IN) was used for PCR amplification. Library-derived cDNA clones, pRD9901, pRD9902, pRD9904 and pRD9905 were in pBluescript SK vector (Stratagene, La
Jolla, CA). pRD9906 and pRD9907 were in pGEM-T vector (Promega, Austin,
TX), derived from RT-PCR with primer pairs RDU2715 (5'-ACT TCA TCA TCC
TTT TCA TCT GTG G-3') and RDD3955 (5'-TGA CGA AGC CCA CGA AGA TAT
TC-3'), and RDU6165 (5'-CTC TCC CAT TGG CTA TGA CTC AC-3') and RDD6945
(5'-GCT ACA AGG TGG TGA TGC AAA TC-3'), respectively. The
(ATG)7 repeat in the 5'-untranslated region (UTR)
was removed by PCR from a library-derived clone, RD9901, with primers
RDU2 (5'-ATA TCG ATG CTA GCT GTT CGT GGA AAT GCA GCA TCA T-3') and
RDD711 (5'-AAT CCA GTA AGT TCC ATC CGT TCC-3'), leaving one ATG as the
single translation initiation site. ClaI and NheI
sites were introduced in the 5'-UTR to facilitate further cloning work.
Standard cloning methods were used to generate four full-length
CaV1.3 1 cDNA clones
containing different combinations of three alternative splice sites
(+/ exon 11, +/ exon 32, and exon 42a/exon 42). Exons are
numbered according to the method of Yamada et al. (1995) , except for
exon 42a, which was present in one of our
CaV1.3 1 cDNA clones and
in the human genomic clone AC012467 that localizes to the
CaV1.3 1 gene (3p14.3).
The cDNAs were cloned into either pcDNA6 (Invitrogen, Carlsbad, CA) or
into pBluescript (Stratagene) for expression. Unless indicated otherwise, the CaV1.3 1
variant used in these studies has the following combination of
alternatively spliced exons: +exon11, exon32, and +exon42a (GenBank
accession number AF370009).
Other clones.
CaV1.2 1 cDNA was
provided by Dr. Y. Mori (National Institute for Physiological Science,
Okazaki, Japan; Mikami et al., 1989 );
CaV 1b cDNA was provided
by Dr. K. P. Campbell (University of Iowa, Iowa City, IA; Pragnell
et al., 1991 ); CaV 2a and
CaV 4 cDNAs were provided
by Dr. E. Perez-Reyes (Loyola University, Marywood, IL; Castellano and
Perez-Reyes, 1994 ), and
CaV 3 and CaV 2 were cloned in
our laboratory. The cDNAs were inserted in either pcDNA3 (Invitrogen)
or pBluescript (Stratagene).
Transient expression and recording from Xenopus
oocytes. Calcium channels were transiently expressed in
Xenopus oocytes, and a two-microelectrode voltage clamp was
used for recordings, essentially as described previously (Lin et al.,
1999 ). Thirty nanograms of CaV1.3 1 or
CaV1.2 1 together with 15 ng of CaV cRNA were injected into
defolliculated Xenopus oocytes in a volume of 46 nl.
Currents were recorded from oocytes 7-9 d after RNA injection. Fifteen to 30 min before recording, oocytes were injected with 46 nl of a 50 mM
1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetate
(BAPTA) solution to reduce activation of the endogenous
calcium-activated chloride current (Lin et al., 1997 ). The estimated
concentration of BAPTA inside the oocyte is 4.5 mM, assuming uniform dispersion from the point of
injection and based on a cell radius of 0.5 mm. L-type calcium channel
currents were recorded using 3 M KCl-filled electrodes with 0.7-1 and 0.4-0.7 M resistances for voltage and current electrodes, respectively. The standard recording solution contained (in mM): 5 BaCl2,
85 tetraethylammonium hydroxide (TEAOH), 5 KCl, and 5 HEPES,
adjusted to pH 7.4 with methanesulphonic acid. When 2 mM BaCl2 or 5 mM CaCl2 was substituted
for 5 mM BaCl2, other
components of the recording solutions remained the same. When 10, 20, and 40 mM BaCl2 were used,
tetraethylammonium was reduced to 75, 55, and 42.5 mM, respectively. The use of 3 M KCl agar bridges for grounding reduced junction
potentials arising from changes in extracellular divalent cation
concentration to <2 mV; therefore, no correction was made. Data were
leak-subtracted on-line using a P/4 protocol (pClamp V6.0; Axon
Instruments). Voltage steps were applied every 12 sec from a holding
potential of 80 mV unless indicated otherwise. Peak current-voltage
plots were fit with the following combination of the
Goldman-Hodgkin-Katz (GHK) and Boltzmann equation to estimate
activation midpoints: I = {P1 × P22 × Vm × (1 exp ( (Vm Vrev × P2))/(1 exp
( (Vm × P2)))}/(1 + exp
( (Vm V1/2)/k)), where
Vm is the membrane potential;
Vrev is the reversal potential;
V1/2 is the activation midpoint;
P1 is the permeability of the ion × [Ca2+]i × RT;
P2 is zF/RT (z,
the valency of the ion; F, the Faraday constant; R, the gas
constant; and T, the temperature in degrees Kelvin); and
k is Boltzmann constant.
Transient transfection and recording from tsA-201 cells.
tsA-201 cells (large T-antigen transformed HEK293 cells) were
transfected with 2.7 µg of a mix of
CaV1.3 1,
CaV 3, and
CaV 2 in a molar ratio
of 1:1:1, together with 0.3 µg of enhanced green florescent protein
cDNA in a 60 mm tissue culture dish with 3 ml of growth media. Cells
were transfected with the various cDNAs when 80% confluent, using
LipofectAMINE-PLUS (Life Technologies, Gaithersburg, MD). Cells were
trypsinized 36 hr later and plated on poly-D-lysine-coated coverslips for recording. Growth media contained DMEM supplemented with
10% FBS, 5 U/ml penicillin, and 5 µg/ml streptomycin, and cells were
cultured at 37°C in 5% CO2.
CaV1.3 1 currents were
recorded from the majority of fluorescing tsA-201 cells (~80%).
Whole-cell voltage-clamp recording was performed with the Axopatch 200A
(Axon Instruments). Recording patch pipettes were fire-polished to a
resistance of 2-6 M . Sylgard (Dow Corning, Midland, MI) was used to
decrease the pipette capacitance. The internal solution contained (in
mM): 135 CsCl, 4 MgCl2, 4 ATP, 10 HEPES, 10 EGTA, and 1 EDTA, adjusted to pH 7.2 with TEAOH. The bath
solution contained: 135 mM CholineCl, 1 mM
MgCl2, 5 mM BaCl2 or 2 mM
CaCl2 and 10 mM HEPES, adjusted to pH
7.2 with TEAOH. Series resistance was compensated 80%, with a 10 µs
lag time. A voltage error of 4 mV attributable to the liquid junction
potential was corrected for. Signals were sampled at 20 kHz and low
pass-filtered at 2 kHz. Data were leak-subtracted on-line using a P/4
protocol and analyzed using pClamp V7.0 (Axon Instruments).
Pharmacology. Bay K 8644 (mixed enantiomer), nimodipine (a
gift from Bayer), and nitrendipine (Sigma, St. Louis, MO) were dissolved in polyethylene glycol 400 at a concentration of 10 mM. (Stock solutions were stored at 4°C in the dark for
up to 1 month.). The extracellular solution was exchanged at a rate of
5-10 ml/min.
 |
RESULTS |
We constructed a full-length
CaV1.3 1 cDNA clone
derived from rat sympathetic neurons. Figure
1 compares current-voltage relationships of L-type Ca channel currents recorded in Xenopus oocytes
expressing either
CaV1.3 1 or
CaV1.2 1 together with
the Ca channel CaV 1b subunit (5 mM barium as charge carrier).
CaV1.3 1 and
CaV1.2 1 currents show
little or no inactivation during a 60 msec depolarizing pulse, a
property typical of L-type currents recorded with barium as the charge
carrier (Fig. 1A). Maximum currents in oocytes
expressing CaV1.2 1 and
CaV1.3 1 subunits were
comparable in amplitude ( 1.5 ± 0.1 µA, n = 6;
and 1.6 ± 0.2 µA, n = 6, respectively).
However, CaV1.3 1
currents activate at voltages significantly more negative compared with
CaV1.2 1. With 5 mM barium as charge carrier,
CaV1.2 1 generates
prototypic, high voltage-activated L-type Ca channel currents that
begin to activate at approximately 35 mV and peak at ~0 mV. In
contrast, CaV1.3 1
currents activate at approximately 55 mV and reach ~60% of peak
current at 40 mV, the very foot of the
CaV1.2 1 current-voltage
plot (Fig. 1B). The large difference in the voltage
dependence of activation between
CaV1.2 1 and
CaV1.3 1 currents was
also observed with 5 mM calcium as the charge
carrier (Fig. 1C, D). Interestingly,
CaV1.3 1 currents showed
more pronounced calcium-dependent inactivation compared with
CaV1.2 1 (Fig.
1C).

View larger version (20K):
[in this window]
[in a new window]
|
Figure 1.
Two classes of L-type Ca channel activate at
different voltages. A, Individual current traces
measured from Xenopus oocytes transiently expressing
Cav1.3 1 (thick traces) and
Cav1.2 1 (thin traces),
together with CaV 1b, using 5 mM barium as the charge carrier. Currents were activated in
response to voltage steps as indicated from a holding potential of 80
mV. B, Averaged, peak current-voltage plots for
Cav1.3 1 ( ) and
Cav1.2 1 ( ) channels using 5 mM barium as charge carrier. C, D, same as
in A and B, except recordings were
obtained using 5 mM calcium as the charge carrier.
V1/2 from peak current-voltage plot: with 5 mM barium as the charge carrier,
Cav1.3 1 and
CaV 1b, 36.8 ± 0.8 mV
(n = 6); Cav1.2 1 and
CaV 1b, 8.8 ± 0.8 mV
(n = 6); with 5 mM calcium as the
charge carrier, 20.0 ± 2.2 mV (n = 4) and
3.3 ± 2.0 mV (n = 4), respectively. Values
are mean ± SE.
|
|
There are reports that native L-type Ca currents in select cells can
activate at relatively hyperpolarized membrane potentials (Smith et
al., 1993 ; Avery and Johnston, 1996 ; Kavalali and Plummer, 1996 ;
Platzer et al., 2000 ), but this is not a feature generally associated
with L-type Ca channels (Ertel et al., 2000 ). Perhaps more perplexing,
earlier studies of cloned
CaV1.3 1 subunits derived from other tissues did not identify this channel as unique with regard
to its voltage dependence of activation (Williams et al., 1992 ; Ihara
et al., 1995 ; Bell et al., 2001 ).
A conspicuous difference in our studies of cloned
CaV1.3 1 channels
compared with others is the use of relatively low concentrations of
divalent cations (5-10-fold lower than those typically used previously, 20 and 40 mM barium; Williams et al., 1992 ;
Ihara et al., 1995 ; Bell et al., 2001 ). Voltage-gated ion channels, including Ca channels, are strongly influenced by the extracellular concentration of divalent cations as a result of surface charge screening effects (Frankenhaeuser and Hodgkin, 1957 ; Kostyuk et al.,
1982 ). This led us to test whether higher divalent cation concentrations might obscure the negative activation threshold of
CaV1.3 1 channels.
Figure 2 demonstrates that an
increase in the extracellular concentration of barium from 2 to 40 mM increases the peak current approximately threefold, but
more significantly, the voltage dependence of channel activation shifts
toward more depolarized membrane potentials (~25 mV). Depolarizations
to 40 mV evoke sizeable Cav1.3 1 currents with 2 mM extracellular barium, whereas the same depolarization
barely activates the channels in 40 mM barium (Fig.
2A). A comparison of averaged, normalized peak
current-voltage plots reveals an incremental shift in the voltage
dependence of Cav1.3 1
channel activation with increasing concentrations of barium. These data
suggest that CaV1.3 1
L-type Ca channels appear to be high-voltage activating when high
concentrations of extracellular divalent cations are used.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 2.
An increase in extracellular divalent cation
concentration shifts the voltage dependence of
CaV1.3 1 activation to depolarized
potentials. A, Individual current traces measured from
Xenopus oocytes transiently expressing
CaV1.3 1 together with
CaV 1b, using 2 mM barium
(thin trace) or 40 mM barium (thick
trace) as the charge carrier. B, C,
CaV1.3 1 channel currents recorded with 2 mM barium ( ), 5 mM barium ( ), 10 mM barium ( ), 20 mM barium ( ), and 40 mM barium ( ). Values plotted are averaged peak currents
measured from each cell normalized to the maximum peak currents
recorded with 5 mM barium (B) and
averaged peak currents normalized to maximum peak current recorded at
each barium concentration (C).
V1/2 from peak current-voltage plots: 2 mM barium, 42.7 ± 1.6 mV (n = 5); 5 mM barium, 33.8 ± 0.8 mV
(n = 5); 10 mM barium, 29.6 ± 1.8 mV (n = 5); 20 mM barium,
24.7 ± 1.2 mV (n = 4); and 40 mM barium, 18.9 ± 1.6 mV (n = 4).
|
|
The data presented in Figure 2 offer one explanation to account for
differences between our findings and those reported previously. However, functional diversity exists among Ca channels containing the
same CaV 1 subunit
because of the potential to associate with different auxiliary subunits
and because each CaV 1
gene is subject to extensive alternative splicing. Either of these
factors at least has the potential to influence the voltage range over
which CaV1.3 1 L-type Ca
channels activate.
At least four different Cav subunits are
expressed in mammals. Each Cav subunit can
associate with multiple
Cav 1 subunits, including
L-type Cav1 1 subunits,
in vitro and in vivo (Pichler et al., 1997 ;
Walker and De Waard, 1998 ). Cav subunits have
been shown to differentially modulate channel properties (Walker and De
Waard, 1998 ). Therefore, we analyzed four
Cav1.3 1/Cav
subunit combinations. All four Cav subunits
facilitated Ca channel current amplitudes compared with
Cav1.3 1 alone (see
legend to Fig. 3A), consistent
with studies of other
Cav 1 subunits (Walker
and De Waard, 1998 ). A comparison of normalized current-voltage plots show that all four
Cav1.3 1-Cav
subunit combinations activate at membrane potentials that are at least
20 mV more hyperpolarized than
CaV1.2 1 (Fig.
3A). We conclude that the association of
Cav1.3 1 with any one of
four different Cav subunits does not account for the large difference in channel activation thresholds that exists
between Cav1.2 1 and
Cav1.3 1.

View larger version (34K):
[in this window]
[in a new window]
|
Figure 3.
CaV1.3 1 channels open
at relatively hyperpolarized voltages independent of several factors
that potentially affect the voltage dependence of activation. Shown are
comparisons of normalized, averaged peak current-voltage plots of
CaV1.3 1 coexpressed with
CaV 1b ( ),
CaV 2a ( ), CaV 3
( ), or CaV 4 ( ) subunits
(A); with ( ) or without ( ) exon 32, which
encodes a 15-amino acid sequence, PSDSENIPLPTATPG, in domain IVS3-IVS4
coexpressed with CaV 1b
(B); with ( ) or without ( ) exon 11, which
encodes a 20-amino acid sequence, CWWKRRGAAKTGPSGCRRWG, in loop I-II
coexpressed with CaV 1b
(C); and with exon 42 ( ) or exon 42a ( )
coexpressed with CaV 1b
(D), Ca channel currents were recorded with 5 mM barium as the charge carrier. Maximum, peak current
amplitudes induced by coexpressing Cav1.3 1
with different CaV subunits were 1.3 ± 0.1 µA
(n = 7; CaV 1b),
2.8 ± 0.2 µA (n = 8;
CaV 2a), 1.0 ± 0.1 µA
(n = 7; CaV 3),
and 1.0 ± 0.5 µA (n = 4;
CaV 4).
Cav1.3 1 alone induced currents with
amplitudes of 0.43 ± 0.05 µA (n = 6).
Average V1/2 values were: A,
33.0 ± 1.0 mV (n = 7;
CaV 1b), 32.1 ± 0.8 mV
(n = 8; CaV 2a),
28.4 ± 0.5 mV (n = 7;
CaV 3), and 30.0 ± 1.0 mV
(n = 4; CaV 4);
B, 35.7 ± 0.5 mV (n = 8;
exon 32) and 31.7 ± 0.7 mV (n = 5; +exon
32); C, 36.1 ± 1.6 mV (n = 8; exon 11) and 35.3 ± 0.6 mV (n = 5;
+exon 11); and D, 33.9 ± 1.5 mV
(n = 3; +exon42) and 32.9 ± 0.4 mV
(n = 5; +exon 42a). Values are mean ± SE.
|
|
CaV 2 , another
auxiliary subunit that associates with
Cav 1, has the potential
to modulate the voltage dependence of channel activation (Wakamori et
al., 1999 ; Platano et al., 2000 ). We therefore compared peak
current-voltage relationships of Ca channels recorded from oocytes
expressing Cav1.3 1 and
Cav 1b in the absence and presence of CaV 2 . The
presence of the CaV 2
subunit did not influence the voltage dependence of
Cav1.3 1 current
activation (V1/2:
Cav1.3 1 and
Cav 1b, 35.3 ± 0.6 mV, n = 6;
Cav1.3 1,
Cav 1b, and
CaV 2 , 36.8 ± 1.2 mV, n = 6) (see Fig.
4).

View larger version (20K):
[in this window]
[in a new window]
|
Figure 4.
CaV1.3 1 channels open
at relatively hyperpolarized voltages independent of expression system.
Shown are normalized, averaged peak-CaV1.3 1
channel current-voltage plots recorded from Xenopus
oocytes expressing CaV1.3 1 and
CaV 3 (5 mM Ba, ) and tsA-201
cells expressing CaV1.3 1,
CaV 3, and
CaV 2 (5 mM Ba, ; and 2 mM Ca, ). Maximum peak currents were 1.0 ± 0.1 µA (n = 7, ), 1.2 ± 0.1 nA
(n = 3, ), and 3.3 ± 1.0 nA
(n = 4, ). Average V1/2 values
were 28.4 ± 0.5 mV (n = 7, ),
26.8 ± 0.7 mV (n = 3, ), and 31.0 ± 0.8 mV (n = 4; ), respectively. Values are
mean ± SE.
|
|
Nascent Cav 1 subunit
RNAs, including Cav1.3 1,
are subject to extensive alternative splicing (Perez-Reyes et al.,
1990 ; Hui et al., 1991 ; Williams et al., 1992 ; Ertel et al.,
2000 ). Alternative splicing occurs throughout the coding region of
Cav 1 subunit genes and
in some cases has been shown to influence the voltage dependence of Ca
channel activation (Lin et al., 1997 ). Although the extent of
alternative splicing in
Cav1.3 1 has yet to be
determined, we have characterized three regions of the gene that
contain exons whose expression is regulated in a tissue-specific manner
(Xu and Lipscombe, 2000 ). Exon 32 encodes 15 amino acids within domain IVS3-IVS4, and exon 11 encodes 20 amino acids in the I-II
intracellular loop. Both these exons are alternatively spliced. Exons
42 and 42a in the C terminus are expressed in a mutually exclusive
manner. The presence of exon 42a predicts a
Cav1.3 1 subunit
containing C termini 500 amino acids shorter than exon 42-containing
subunits (GenBank accession number AF370010). We constructed four
splice variants of
Cav1.3 1 that differ in
the expression of each exon and compared their properties (Fig.
3B-D). The current-voltage relationships of all
Cav1.3 1 splice variants
were virtually indistinguishable, and all activated at voltages that
were ~20 mV more hyperpolarized than that of
Cav1.2 1.
Finally, we studied the properties of
Cav1.3 1 channel currents
transiently expressed in a mammalian kidney cell line together with
CaV 2 and
Cav 3 (5 mM
barium as charge carrier).
Cav1.3 1 L-type currents
expressed in tsA-201 cells are indistinguishable from those recorded in
Xenopus oocytes (Fig. 4). The current-voltage curve of
Cav1.3 1 L-type channel
currents transiently expressed in tsA-201 cells with 2 mM calcium as the charge carrier is also shown to
indicate the probable activation threshold of this current in neurons.
Note that the position of the
Cav1.3 1 current-voltage curve with 2 mM calcium is comparable with that
recorded in 5 mM barium (Fig. 4). This is
consistent with previous studies showing that calcium is more effective
at shifting the gating of voltage-gated ion channels compared with
barium (Hille, 1992 ).
Figures 1-4 demonstrate that L-type Ca channels are not all high
voltage-activated as often assumed. However, in addition to biophysical
criteria, L-type Ca channels are also, and more often, defined by their
high sensitivity to dihydropyridine agonists and antagonists (Bean,
1989 ; Ertel et al., 2000 ). We therefore studied the pharmacological
sensitivity of Cav1.3 1
and Cav1.2 1 to
dihydropyridines. Bay K 8644 augmented
Cav1.3 1 L-type currents and induced an ~10 mV shift in the voltage dependence of activation toward more hyperpolarized voltages compared with control (Fig. 5). Bay K 8644 also slowed channel
activation and deactivation kinetics, consistent with its effects on
other Cav 1 1 L-type currents (Grabner et al., 1996 ).
Cav1.3 1 L-type channel
currents were also inhibited by the dihydropyridine antagonist
nimodipine. The degree of nimodipine-induced inhibition of
Cav1.3 1 channel currents, however, differed significantly compared with
Cav1.2 1. At 1 µM, nimodipine inhibited ~90% of the
Cav1.2 1 channel current at voltages between 20 and +40 mV, whereas at the same
concentration, peak
Cav1.3 1 currents were
inhibited ~50% at most (Fig. 6).
Nimodipine was less effective at inhibiting both classes of L-type Ca
channels at threshold voltages (Fig. 6C), consistent with a
state-dependent blocking mechanism (Bean, 1984 ; Hess et al., 1984 ).
Inhibition of peak
Cav1.2 1 currents was,
nonetheless, significantly greater compared with
Cav1.3 1 at all membrane
potentials (Fig. 6B,C). An examination of individual
current traces shows that nimodipine induces an acceleration of the
decay of the residual
Cav1.3 1 current (Fig.
6A). However, even after a 60 msec depolarization, ~30% of the Cav1.3 1
current remained unblocked in the presence of 1 µM nimodipine. Figure
7A summarizes the
pharmacological differences between
Cav1.3 1 and
Cav1.2 1 channels
revealed by nimodipine. Cav1.3 1 channels are
~20-fold less sensitive to inhibition by nimodipine compared with
Cav1.2 1 (Fig.
7A). Even at 10 µM, nimodipine did
not completely inhibit the
Cav1.3 1 current. The
relatively low sensitivity of
Cav1.3 1 to inhibition by
dihydropyridine was confirmed using a second antagonist, nitrendipine
(Fig. 7B). At 1 and 10 µM,
nitrendipine reduced peak
Cav1.2 1 currents by
64 ± 3% (n = 4) and 81 ± 1%
(n = 4), respectively, but at these same concentrations
only inhibited Cav1.3 1
currents by 23 ± 1% (n = 8) and 53 ± 2%
(n = 8), respectively. The pharmacological sensitivity of Cav1.3 1 channels to
dihydropyridine antagonists was unaffected by the presence or absence
of exon 32 in the putative extracellular IVS3-IVS4 linker (Fig.
7B). Finally, we tested the effectiveness of the classic
N-type Ca channel toxin -conotoxin GVIA to inhibit Cav1.3 1 channels. Others
have reported that
Cav1.3 1 channels are
reversibly inhibited by high concentrations of this toxin (Williams et
al., 1992 ). -Conotoxin GVIA did not inhibit
Cav1.3 1 channel currents
at concentrations up to 1 µM (99.0 ± 1.6%; n = 6, compared with control).

View larger version (22K):
[in this window]
[in a new window]
|
Figure 5.
CaV1.3 1 currents were
enhanced by Bay K 8644. A,
CaV1.3 1 currents in the absence
(left) and presence (right) of 1 µM Bay K 8644. Currents were activated from a holding
potential of 80 mV. B, Averaged, peak current-voltage
plots of CaV1.3 1 channels recorded with 5 mM barium in control ( ) and in the presence of 1 µM Bay K 8644 ( ). Maximum peak currents were
0.4 ± 0.1 µA (n = 3, ) and 0.7 ± 0.1 µA (n = 3, ). Average
V1/2 values were 32.2 ± 1.1 mV in control
(n = 3, ) and 39.0 ± 2.5 mV in the
presence of Bay K 8644 (n = 3, ).
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Figure 6.
CaV1.3 1 currents are
partially inhibited by dihydropyridines. A,
CaV1.3 1 (top) and
CaV1.2 1 (bottom) in the
absence (thick traces) and presence (thin
traces) of 1 µM nimodipine. Currents were
activated by voltage steps as indicated, from a holding potential of
80 mV. B, Comparison of normalized, averaged peak
current-voltage plots of CaV1.3 1 and
CaV1.2 1 channels in the absence ( , )
and presence ( , ) of 1 µM nimodipine, respectively.
C, Peak CaV1.3 1 (light
gray) and peak CaV1.2 1 (dark
gray) currents remaining in the presence of nimodipine, plotted
as percentage of control currents at various test potentials. Values
are mean ± SE; n = 6 for
CaV1.3 1 and n = 3 for
CaV1.2 1.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Figure 7.
CaV1.3 1 and
CaV1.2 1 channels are pharmacologically
distinct. A, Dose-response curve of nimodipine
inhibition of CaV1.3 1 ( ) and
CaV1.2 1 ( ) channel currents. Data were
fit to the Hill equation: (Icontol Inimodipine)/Icontrol = 1/(1 + (IC50/Cnimodipine)h),
where IC50 is the concentration of nimodipine required to
inhibit 50% of peak current, and h is the Hill
coefficient. CaV1.3 1,
IC50 = 2.7 ± 0.3 µM;
h = 0.85 ± 0.04 (n = 5);
CaV1.2 1, IC50 = 139 ± 12 nM; h = 0.63 ± 0.05 (n = 5). B, Inhibition of
CaV1.3 1 ( exon 32, light
gray, n = 8; +exon 32, dark
gray, n = 6) and
CaV1.2 1 (white,
n = 4) by nitrendipine are significantly different
at concentrations of 1 and 10 µM. Values are mean ± SE.
|
|
 |
DISCUSSION |
Cav1.3 1 L-channels open at relatively
hyperpolarized membrane potentials
Our results suggest that calcium channels that contain the
Cav1.3 1 subunit are not
typical high voltage-activated L-type channels, and our study
highlights the large difference in activation thresholds (~25 mV)
between the two major classes of L-type channels expressed in neurons.
This difference appears to stem from intrinsic differences between
Cav1.2 1 and
Cav1.3 1 genes, because
it is independent of auxiliary subunits, alternative splicing in at least three different domains of the protein, and expression system (Figs. 3, 4). Given the unusually hyperpolarized activation threshold of Cav1.3 1 channels
observed in our studies, it is perhaps surprising that this unique
property has not been highlighted in previous studies of other
Cav1.3 1 clones (Williams
et al., 1992 ; Ihara et al., 1995 ; Bell et al., 2001 ). Although we
cannot exclude the possibility that specific variants of
Cav1.3 1 derived from
other tissues or cell lines differ from our clones with respect to
activation thresholds, we suggest that the use of high concentrations
of extracellular divalent cations in certain studies may have obscured the unusually hyperpolarized activation range of
Cav1.3 1 channels. For
example, if our data are compared with those of Williams et al. (1992)
under similar recording conditions (40 mM barium; Fig. 2),
the Cav1.3 1 L-type
current-voltage relationships are comparable. With 40 mM
barium, the Cav1.3 1
current-voltage relationship is shifted to ~20 mV more depolarized.
Cav1.3 1 L-type currents
expressed in HEK293 cells (Bell et al., 2001 ; 20 mM barium)
and Chinese hamster ovary cells (Ihara et al., 1995 ; 40 mM
barium), however, activate at membrane potentials more depolarized
compared with our data and with that of Williams et al. (1992) , even
after considering the effect of surface charge screening. The reasons
for these differences are not apparent, given that Bell et al. (2001)
used the same clone as that of Williams et al. (1992) , and our results suggest that different expression systems do not influence the voltage
dependence of Cav1.3 1
L-type channel activation (Fig. 4).
Is there evidence that native L-type
Cav1.3 1 currents
activate at hyperpolarized membrane potentials? Our studies of cloned Cav1.3 1 channels suggest
that they activate at membrane potentials significantly more
hyperpolarized than any
Cav1 1 or
Cav2 1 channel described
to date.
Cav1.3 1-containing
L-type channels begin to activate at approximately 55 mV in the
presence of 5 mM barium or 2 mM calcium, not as
hyperpolarized as members of the T-type family but significantly more
hyperpolarized relative to Cav
2.3 1-containing ( 1E)
channels (Perez-Reyes et al., 1998 ). Consistent with our studies of
cloned channels, certain cells that express high levels of
Cav1.3 1, such as hair
cells and endocrine cells, contain native L-type Ca channels that
activate at membrane potentials close to 50 mV (Smith et al., 1993 ;
Zidanic and Fuchs, 1995 ; Kollmar et al., 1997 ). Perhaps most
significantly, there is a selective loss of a low threshold-activating
component of the whole cell Ca current in inner hair cells in
Cav1.3 1-deficient mice
(Platzer et al., 2000 ).
Although complicated by the presence of multiple classes of Ca channels
with overlapping properties, there is evidence for the presence of low
threshold-activating L-type Ca channels in neurons. For example, a
component of low threshold-activating Ca current in CA3 pyramidal
neurons of the hippocampus is reduced by high concentrations of
dihydropyridines (Avery and Johnston, 1996 ). Furthermore, L-type Ca
currents are thought to underlie spontaneous calcium oscillations that
drive intrinsic activity in immature Purkinje cells of the cerebellum
(Liljelund et al., 2000 ). Ca channels that drive spontaneous electrical
activity are thought typically to activate at hyperpolarized membrane
potentials (Bean, 1989 ). There is also evidence for the presence of two
functionally distinct classes of L-type Ca channels from single-channel
recordings in hippocampal neurons that differ significantly in their
activation thresholds (Kavalali and Plummer, 1994 , 1996 ). It would be
interesting to test whether
Cav1.2 1- and
Cav1.3 1-containing
channels underlie these different channels, because both these genes
are expressed in the hippocampus (Hell et al., 1993 ). Our clone was
isolated from sympathetic neurons, suggesting that a low-threshold
L-type current exists in these cells. There is a low
threshold-activating dihydropyridine- and conotoxin-resistant Ca
current in sympathetic neurons that has been described in both
whole-cell and single-channel recordings (Boland et al., 1994 ; Elmslie
et al., 1994 ; Elmslie, 1997 ). It would be interesting to know whether
at least part of the resistant current in sympathetic neurons
originates from the activity of
Cav1.3 1-containing
channels (see below).
Cav1.3 1 calcium channels are less
sensitive to dihydropyridine antagonists
High sensitivity to dihydropyridines is the universal indicator
for the involvement of L-type calcium channels. However, at concentrations typically assumed to inhibit the majority of L-type Ca
channels, ~50% of the peak
Cav1.3 1 channel current
remains unblocked in the presence of dihydropyridines (Figs. 6, 7).
Support for the presence of native L-type channels in neurons that are incompletely inhibited by dihydropyridine antagonists is not simple to
extract from available studies because of the prevalence of multiple
classes of non-dihydropyridine-sensitive Ca channels in these cells.
However, native L-type Ca currents in hair cells that express a
relatively high density of
Cav1.3 1 channels are incompletely inhibited by high concentrations of dihydropyridines (Zidanic and Fuchs, 1995 ; Platzer et al., 2000 ).
An additional feature of the dihydropyridine block of
Cav1.3 1 channels is the
altered inactivation kinetics of the residual Ca channel current.
Although our study was not designed to address that mechanism, the
dihydropyridine-induced inactivation profile is consistent with a
state-dependent blocking model described for both native and cloned
L-type Ca channels (Bean, 1984 ; Berjukow et al., 2000 ). It is of
interest, however, that high concentrations of dihydropyridines induce
residual Cav1.3 1 L-type
currents to inactivate during brief depolarizations, because similar
low to mid threshold-activating and -inactivating and drug-resistant Ca
channel currents have been described in a variety of neurons (Randall
and Tsien, 1995 ; Avery and Johnston, 1996 ; Tottene et al., 1996 ). Such
drug-resistant currents (or R-type currents) revealed by a mixture of
Ca channel blockers that includes dihydropyridine antagonists have been
attributed to the presence of non-L-type Cav2.3 1
( 1E) subunits (Randall and Tsien, 1995 ;
Tottene et al., 1996 ).
Cav2.3 1 currents
activate at somewhat hyperpolarized membrane potentials, inactivate
with a relatively fast time course, and are resistant to various Ca
channel blockers, including dihydropyridine antagonists (Ellinor et
al., 1993 ; Randall and Tsien, 1995 ). However, the prevalence of
significant drug-resistant Ca current in neurons of
Cav2.3 1-deficient mice
suggests that other Cav 1
subunits in addition to
Cav2.3 1 contribute to
this current (Wilson et al., 2000 ). On the basis of their similarities
overall, it is likely that
Cav1.3 1-containing
channels underlie a significant fraction of the resistant Ca current
described in neurons in the presence of Ca channel blockers.
Functional implications
L-type Ca channels have been implicated in regulating gene
expression, cell survival, and synaptic plasticity in neurons (Galli et
al., 1995 ; Norris et al., 1998 ; Mao et al., 1999 ; Weisskopf et al.,
1999 ) and in supporting exocytosis in hair cells and pancreatic cells (Ashcroft et al., 1994 ; Fuchs, 1996 ). However, our studies suggest that functional and pharmacological criteria currently used to
distinguish among different Ca currents probably greatly underestimate
the biological importance of L-type Ca channels in neurons expressing
Cav1.3 1. The unique
functional properties of
Cav1.3 1 compared with
Cav1.2 1 highlighted in
the present study combine with evidence of distinct subcellular
localization patterns (Hell et al., 1993 ) to imply that these two
classes of L-type Ca channels may couple to different signaling
pathways. Because of their unique properties,
Cav1.3 1 channels are
likely to be important for mediating Ca influx in response to
relatively small membrane depolarizations, and our preliminary analysis
of the voltage dependence of steady-state inactivation suggests that Cav1.3 1 L-type channels
possess a significant window current at membrane potentials close to
50 mV. Such properties may be important for sustaining spontaneous
rhythmic firing in neurons, traditionally attributed to the activity of
low-threshold, T-type Ca channels (Bean, 1989 ; Ertel et al., 2000 ).
Consistent with this, the dihydropyridine antagonist nimodipine
partially suppresses spontaneous intracellular calcium oscillations and
slows rhythmic firing in postnatal cerebellar Purkinje cells (Liljelund
et al., 2000 ). More direct evidence for the involvement of
Cav1.3 1 L-type Ca
channels in driving rhythmic activity in excitable cells comes from
studies of
Cav1.3 1-deficient mice
whose phenotype includes compromised sinoatrial node function (Platzer
et al., 2000 ). A selective inhibitor of the
Cav1.3 1 L-type current
would greatly aid in establishing its contribution to the whole-cell Ca
current in neurons and consequently its importance in coupling to
downstream signaling pathways.
In summary, analysis of recombinant neuron-derived
Cav1.3 1 channels has
permitted functional and pharmacological characterization of this class
of Ca current, which has been lacking. The unique properties of
Cav1.3 1 contrast with
the standard view of L-type Ca channels as high voltage-activated and
highly sensitive to dihydropyridines and suggests that new functional
roles for Cav1.3 1 L-type
channels will be forthcoming.
Note added in proof. Properties similar to
those described here were reported recently for a Cav
1.3 1 subunit isolated from human pancreas (Koschak et
al., 2001 ).
 |
FOOTNOTES |
Received April 16, 2001; revised May 25, 2001; accepted May 31, 2001.
This work was supported by National Institutes of Health Grants NS29967
and NS01927. We thank Dr. Yasuo Mori for providing Cav1.2 1 cDNA, Drs. Kevin Campbell and
Derrick Witcher for Cav 1b cDNA, and Dr.
Edward Perez-Reyes for Cav 2a and
Cav 4 cDNAs. We thank Christopher Thaler and
Annette Gray for their helpful comments on this manuscript.
Correspondence should be addressed to Diane Lipscombe, Department of
Neuroscience, Brown University, 192 Thayer Street, Providence, RI
02912. E-mail: Diane_Lipscombe{at}brown.edu.
 |
REFERENCES |
-
Ashcroft FM,
Proks P,
Smith PA,
Ammala C,
Bokvist K,
Rorsman P
(1994)
Stimulus-secretion coupling in pancreatic beta cells.
J Cell Biochem
55:54-65.
-
Avery RB,
Johnston D
(1996)
Multiple channel types contribute to the low-voltage-activated calcium current in hippocampal CA3 pyramidal neurons.
J Neurosci
16:5567-5582[Abstract/Free Full Text].
-
Beam KG,
Tanabe T,
Numa S
(1989)
Structure, function, and regulation of the skeletal muscle dihydropyridine receptor.
Ann NY Acad Sci
560:127-137[ISI][Medline].
-
Bean BP
(1984)
Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state.
Proc Natl Acad Sci USA
81:6388-6392[Abstract/Free Full Text].
-
Bean BP
(1989)
Classes of calcium channels in vertebrate cells.
Annu Rev Physiol
51:367-384[ISI][Medline].
-
Bell DC,
Butcher AJ,
Berrow NS,
Page KM,
Brust PF,
Nesterova A,
Stauderman KA,
Seabrook GR,
Nurnberg B,
Dolphin AC
(2001)
Biophysical properties, pharmacology, and modulation of human, neuronal L-type (
1D, CaV1.3) voltage-dependent calcium currents.
J Neurophysiol
85:816-827[Abstract/Free Full Text]. -
Berjukow S,
Marksteiner R,
Gapp F,
Sinnegger MJ,
Hering S
(2000)
Molecular mechanism of calcium channel block by isradipine. Role of a drug-induced inactivated channel conformation.
J Biol Chem
275:22114-22120[Abstract/Free Full Text].
-
Boland LM,
Morrill JA,
Bean BP
(1994)
-Conotoxin block of N-type calcium channels in frog and rat sympathetic neurons.
J Neurosci
14:5011-5027[Abstract]. -
Castellano A,
Perez-Reyes E
(1994)
Molecular diversity of Ca2+ channel beta subunits.
Biochem Soc Trans
22:483-488[ISI][Medline].
-
Ellinor PT,
Zhang JF,
Randall AD,
Zhou M,
Schwarz TL,
Tsien RW,
Horne WA
(1993)
Functional expression of a rapidly inactivating neuronal calcium channel.
Nature
363:455-458[Medline].
-
Elmslie KS,
Kammermeier PJ,
Jone SW
(1994)
Reevaluation of Ca2+ channel types and their modulation in bullfrog sympathetic neurons.
Neuron
13:17-28.
-
Elmslie KS
(1997)
Identification of the single channels that underlie the N-type and L-type calcium currents in bullfrog sympathetic neurons.
J Neurosci
17:2658-2668[Abstract/Free Full Text].
-
Ertel EA,
Campbell KP,
Harpold MM,
Hofmann F,
Mori Y,
Perez-Reyes E,
Schwartz A,
Snutch TP,
Tanabe T,
Birnbaumer L,
Tsien RW,
Catterall WA
(2000)
Nomenclature of voltage-gated calcium channels [letter, comment].
Neuron
25:533-535[ISI][Medline].
-
Finkbeiner S,
Greenberg ME
(1998)
Ca2+ channel-regulated neuronal gene expression.
J Neurobiol
37:171-189[ISI][Medline].
-
Frankenhaeuser B,
Hodgkin AL
(1957)
The action of calcium on the electrical properties of squid axons.
J Physiol (Lond)
137:218-244.
-
Fuchs PA
(1996)
Synaptic transmission at vertebrate hair cells.
Curr Opin Neurobiol
6:514-519
|